The content on this site is intended for healthcare professionals only
ASCO Direct Highlights 2022: prostate cancer highlights
Dr Chandler Park - Baptist Health Hardin, Elizabethtown, USA
9 Jul 2022
Updates in bladder, kidney and testes cancer from ASCO 2022
Dr Winston Tan - Mayo Clinic, Jacksonville, USA
9 Jul 2022
Cancer patient symptom and physical function reporting by caregivers used as pre...
Dr Elad Neeman - Kaiser Permanente San Francisco Medical Center, San Francisco, ...
21 Jun 2022
War in Ukraine: Global cancer aid to support refugees
Dr Horia Vulpe , Dr Ruslan Baltaga
21 Jun 2022
ASCO 2022: The latest in mRCC
Prof James Larkin, Dr Bernard Escudier, Prof Jens Bedke and Dr Toni Choueiri
17 Jun 2022
ASCO and WHO to collaborate on quality indicators for cancer facilities
Dr André Ilbawi - WHO Headquarters, Geneva, Switzerland
14 Jun 2022
Spotlight on global cancer control at ASCO 2022
Prof Eduardo Cazap - Editor-in-Chief, ecancer and SLACOM
10 Jun 2022
UICC announces global coalition to increase access to essential cancer medicines...
Dr Cary Adams - Chief Executive Officer, Union for International Cancer Control
9 Jun 2022
ASCO 2022: Panel discussion on bladder preservation
Dr Petros Grivas, Prof Rob Jones, Prof Phil Cornford and Prof Kurt Miller
6 Jun 2022
ASCO 2022: Highlights and analysis
Dr Bishal Gyawali - Queen's University, Kingston, Canada
6 Jun 2022
ASCO 2022: Latest in prostate cancer, including PARP inhibitors
Dr Neal Shore, Prof Cora Sternberg, Prof Eleni Efstathiou and Prof Phil Cornford
6 Jun 2022
ASCO 2022: Latest developments in mHSPC and mCRPC
Prof Heather Payne, Prof Kim Chi, Prof Laura-Maria Krabbe and Prof Kurt Miller
6 Jun 2022